Authors:
Washburn, WN
Sher, PM
Poss, KM
Girotra, RN
McCann, PJ
Gavai, AV
Mikkilineni, AB
Mathur, A
Cheng, P
Dejneka, TC
Sun, CQ
Wang, TC
Harper, TW
Russell, AD
Slusarchyk, DA
Skwish, S
Allen, GT
Hillyer, DE
Frohlich, BH
Abboa-Offei, BE
Cap, M
Waldron, TL
George, RJ
Tesfamariam, B
Ciosek, CP
Ryono, D
Young, DA
Dickinson, KE
Seymour, AA
Arbeeny, CM
Gregg, RE
Citation: Wn. Washburn et al., Beta 3 agonists. Part 1: Evolution from inception to BMS-194449, BIOORG MED, 11(23), 2001, pp. 3035-3039
Authors:
Gavai, AV
Sher, PM
Mikkilineni, AB
Poss, KM
McCann, PJ
Girotra, RN
Fisher, LG
Wu, G
Bednarz, MS
Mathur, A
Wang, TC
Sun, CQ
Slusarchyk, DA
Skwish, S
Allen, GT
Hillyer, DE
Frohlich, BH
Abboa-Offei, BE
Cap, M
Waldron, TL
George, RJ
Tesfamariam, B
Harper, TW
Ciosek, CP
Young, DA
Dickinson, KE
Seymour, AA
Arbeeny, CM
Washburn, WN
Citation: Av. Gavai et al., BMS-196085: A potent and selective full agonist of the human beta(3) adrenergic receptor, BIOORG MED, 11(23), 2001, pp. 3041-3044
Authors:
Robl, JA
Sulsky, R
Sieber-McMaster, E
Ryono, DE
Cimarusti, MP
Simpkins, LM
Karanewsky, DS
Chao, S
Asaad, MM
Seymour, AA
Fox, M
Smith, PL
Trippodo, NC
Citation: Ja. Robl et al., Vasopeptidase inhibitors: Incorporation of geminal and spirocyclic substituted azepinones in mercaptoacyl dipeptides, J MED CHEM, 42(2), 1999, pp. 305-311
Citation: B. Tesfamariam et al., Quantitation of tremor in response to beta-adrenergic receptor stimulationin primates: Relationship with hypokalemia, J PHARM TOX, 40(4), 1998, pp. 201-205
Authors:
Murugesan, N
Gu, ZX
Stein, PD
Bisaha, S
Spergel, S
Girotra, R
Lee, VG
Lloyd, J
Misra, RN
Schmidt, J
Mathur, A
Stratton, L
Kelly, YF
Bird, E
Waldron, T
Liu, ECK
Zhang, RG
Lee, H
Serafino, R
Abboa-Offei, B
Mathers, P
Giancarli, M
Seymour, AA
Webb, ML
Moreland, S
Barrish, JC
Hunt, JT
Citation: N. Murugesan et al., Biphenylsulfonamide endothelin antagonists: Structure-activity relationships of a series of mono- and disubstituted analogues and pharmacology of theorally active endothelin antagonist 2 '-amino-N-(3,4-dimethyl-5-isoxazolyl)-4 '-(2-methylpropyl)[1,1 '-biphenyl]-2-sulfonamide (BMS-187308), J MED CHEM, 41(26), 1998, pp. 5198-5218